Test second generation RNA Polymerase I inhibitors for their anti-cancer activity
This study assesses the potential of second-generation RNA Polymerase I inhibitors as therapeutic agents for cancer by evaluating their ability to inhibit cancer cell growth and proliferation.
Student intake
This project is open for Honours, Masters and PhD students.
Group
Research theme
Research themes
Project status
Project status
Potential
Contact
Contact
Content navigation
About
This study evaluates the anti-cancer activity of second-generation RNA Polymerase I inhibitors. By testing their effectiveness in inhibiting cancer cell growth and proliferation, the research aims to assess their potential as therapeutic agents against cancer.
Members
Supervisor
Senior Fellow
Group Leader
Deputy Dean, Research, CHM
NHMRC Principle Res. Fellow
Senior Fellow